Literature DB >> 8266413

Antimonial treatment of hamsters infected with Leishmania (Viannia) panamensis: assessment of parasitological cure with different therapeutic schedules.

B L Travi1, J E Martinez, A Zea.   

Abstract

The objective of the study was to establish the effective dose and route of administration of Glucantime for treating hamsters infected with Leishmania (Viannia) panamensis and to use this method to test new treatment regimens to attain clinical and parasitological cure. In the first experiments animals were inoculated subcutaneously in the hind foot with 5 x 10(6) promastigotes of L. panamensis (HOM/COL/84/1099) from a 6 d culture. One month after inoculation, Glucantime was administered intramuscularly (i.m.) at 20, 40 or 60 mg/kg/d for 20 d to groups of hamsters. Only 60 mg/kg/d resulted in both clinical improvement and parasite elimination from the skin and draining lymph node. In the second set of experiments, i.m., local and combined antimonial regimens were compared. The local regimen, of 4 intralesional (i.l.) injections of 4 mg of antimony at 5 d intervals, and the combined regimen (i.m. and i.l.), were more efficient at clearing parasites than the systemic (i.m.) schedule, especially when a low dosage of Glucantime (30 mg/kg/d x 20 d) was used. The results suggest that combining local treatment and low systemic dosages of antimonials results in clearance of L. panamensis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8266413     DOI: 10.1016/0035-9203(93)90093-6

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  3 in total

1.  In vitro and in vivo cytotoxicities and antileishmanial activities of thymol and hemisynthetic derivatives.

Authors:  Sara Robledo; Edison Osorio; Diana Muñoz; Luz Marina Jaramillo; Adriana Restrepo; Gabriel Arango; Iván Vélez
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

2.  Cutaneous leishmaniasis in the dorsal skin of hamsters: a useful model for the screening of antileishmanial drugs.

Authors:  Sara M Robledo; Lina M Carrillo; Alejandro Daza; Adriana M Restrepo; Diana L Muñoz; Jairo Tobón; Javier D Murillo; Anderson López; Carolina Ríos; Carol V Mesa; Yulieth A Upegui; Alejandro Valencia-Tobón; Karina Mondragón-Shem; Berardo Rodríguez; Iván D Vélez
Journal:  J Vis Exp       Date:  2012-04-21       Impact factor: 1.355

3.  Body weight as a determinant of clinical evolution in hamsters (Mesocricetus auratus) infected with Leishmania (Viannia) panamensis.

Authors:  Angela María Gómez-Galindo; Lucy Gabriela Delgado-Murcia
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2013 Sep-Oct       Impact factor: 1.846

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.